WSJ: Theranos is voiding and revising previous blood check outcomes
As Theranos faces elevated scrutiny from regulators, tonight the Wall Road Journal is reporting the corporate is taking a unprecedented step by voiding its personal blood check outcomes going again two years. Based on the Journal, the corporate is telling the Facilities for Medicare and Medicaid Providers that it has issued “tens of hundreds” of corrected blood check studies, masking outcomes which were revised or voided altogether.
Docs confirmed receiving up to date outcomes, and Theranos says in a press release that “Excellence in high quality and affected person security is our prime precedence and we have taken complete corrective measures to deal with the problems CMS raised of their observations. As these issues are at present underneath assessment, we have now no additional remark presently.”
The corrections aren’t restricted to checks Theranos carried out with its “fingerprick” Edison know-how both, as a Journal supply reported its Arizona lab was utilizing a standard blood testing machine from Siemens with the incorrect settings. Theranos is reportedly making an attempt to keep away from stiff penalties that would embrace banning its founder Elizabeth Holmes from the blood testing business, and has just lately made vital modifications in its organizational construction. In October Holmes initially defended the integrity of her firm’s processes towards costs of inaccuracy, however a lot of the information leaking out since then has not supported that view.